Policies and Procedures

For a public biotech company like Rhino Biotech Limited listed on the OTC Markets, some of the most important policies and procedures include:

1. Corporate Governance

  • Board of Directors: Outlines the responsibilities of the board, including oversight of the company’s strategic direction and risk management. The governance structure must include independent directors and committee functions, such as audit and compensation.
  • Code of Conduct: Sets standards for ethical behavior, integrity, and compliance with laws and regulations. This includes interactions with stakeholders, transparency, and conflicts of interest.
  • Insider Trading Policy: Defines the rules surrounding the buying and selling of company shares by employees, officers, and directors to prevent insider trading violations.

2. Financial Reporting and Disclosure

  • SEC Filings: As a public company, Rhino Biotech Limited must comply with SEC reporting requirements, such as filing 10-Ks, 10-Qs, 8-Ks, and proxy statements, to ensure transparency and accurate financial disclosure to investors.
  • Sarbanes-Oxley Act (SOX) Compliance: Ensures that the company adheres to internal controls for financial reporting and that there is an accurate accounting of the company’s financial status. This includes auditing, fraud prevention, and executive accountability.
  • Auditor Engagement: Policy on the appointment of independent auditors and procedures for regular audits to ensure the company’s financial statements are accurately represented.

3. Research and Development (R&D)

  • Clinical Trial Procedures: Rhino Biotech must adhere to strict guidelines for the conduct of clinical trials, including patient recruitment, data integrity, and safety monitoring, ensuring compliance with FDA regulations and Good Clinical Practice (GCP).
  • Intellectual Property (IP) Management: Procedures to protect the company’s IP, including patents, trademarks, and trade secrets. This policy ensures proper filing, maintenance, and defense of IP rights.
  • Ethical Considerations: Ensures all research is conducted ethically, particularly with human or animal subjects. This includes obtaining informed consent and following ethical guidelines set forth by relevant bodies.

4. Compliance with FDA and Regulatory Requirements

  • Regulatory Affairs: Ensures the company complies with all applicable laws and regulations related to biotechnology products. This includes the FDA's approval process, compliance with 21 CFR regulations, and other relevant government bodies.
  • Safety and Quality Control: Ensures that products meet quality standards and are safe for consumer use, involving adherence to cGMP (current Good Manufacturing Practices) during the production of biotech products.

5. Investor Relations and Shareholder Communications

  • Communication Policy: Ensures that the company communicates important information to shareholders and the public in a timely and accurate manner, including quarterly earnings reports, press releases, and corporate announcements.
  • Disclosure Controls: Policy ensuring that material information is disclosed to the public, and the company adheres to regulations about selective disclosure, insider trading, and managing market rumors.

6. Employee and Workplace Policies

  • Employment Practices: Ensures fair treatment of employees, with policies on recruitment, discrimination, harassment, and diversity. It also includes compliance with labor laws and wage standards.
  • Health and Safety: Policies to ensure a safe and healthy work environment, particularly for biotech-related laboratories or manufacturing facilities, including hazardous materials handling, biosecurity, and emergency procedures.
  • Confidentiality and Data Protection: Guidelines for handling proprietary information and personal data, complying with regulations such as GDPR for international data protection or HIPAA if applicable.

7. Environmental and Social Responsibility

  • Environmental Sustainability: Procedures to minimize environmental impact, including waste management, energy use, and sustainability practices in manufacturing or research facilities.
  • Corporate Social Responsibility (CSR): Outlines the company’s commitment to giving back to the community, including philanthropic efforts, ethical sourcing, and other socially responsible practices.

8. Risk Management

  • Risk Assessment Procedures: Identifies and evaluates financial, operational, and strategic risks, including risks related to product development, market conditions, and regulatory compliance.
  • Crisis Management: Procedures to manage potential crises, whether from product failures, regulatory enforcement, public relations issues, or financial troubles.

These policies and procedures are critical for maintaining investor confidence, ensuring compliance with legal standards, and fostering sustainable growth and ethical practices within the biotech industry.